abt-263
Showing 1 - 17 of 17
Chronic Lymphocytic Leukemia Trial in Worldwide (ABT-263)
Completed
- Chronic Lymphocytic Leukemia
- ABT-263
-
La Jolla, California
- +9 more
Jul 8, 2022
Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma Trial in Canada, United States (ABT-263)
Completed
- Chronic Lymphoid Leukemia
- +5 more
- ABT-263
-
Los Angeles, California
- +11 more
Jul 28, 2021
Platinum-resistant or Refractory Ovarian Cancer Trial in France (ABT-263)
Completed
- Platinum-resistant or Refractory Ovarian Cancer
- ABT-263
-
Besançon, France
- +15 more
Mar 15, 2019
Small Cell Lung Cancer, Small Cell Lung Carcinoma Trial in Canada, United Kingdom, United States (ABT-263)
Completed
- Small Cell Lung Cancer
- Small Cell Lung Carcinoma
- ABT-263
-
Peoria, Arizona
- +17 more
Jun 1, 2018
Lymphoid Malignancy, Solid Tumors Trial (ABT-263)
Completed
- Lymphoid Malignancy
- Solid Tumors
- ABT-263
- (no location specified)
Nov 17, 2017
Solid Tumors Trial in United States (ABT-263, erlotinib, irinotecan (3-week schedule))
Completed
- Solid Tumors
- ABT-263
- +3 more
-
Santa Monica, California
- +3 more
Nov 16, 2017
Prostate Cancer Trial in New Brunswick (Abiraterone, ABT-263, Hydroxychloroquine)
Terminated
- Prostate Cancer
- Abiraterone
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Mar 30, 2017
Chronic Lymphocytic Leukemia Trial in United States (ABT-263, FCR, BR)
Completed
- Chronic Lymphocytic Leukemia
- ABT-263
- +2 more
-
La Jolla, California
- +5 more
Jun 5, 2013
Lymphoma, Chronic Lymphocytic Leukemia, Solid Tumors Trial in San Antonio (ABT-263, Ketoconazole)
Completed
- Lymphoma
- +2 more
- ABT-263
- Ketoconazole
-
San Antonio, TexasSite Reference ID/Investigator# 25068
Dec 16, 2010
Healthy Female Subjects Trial in Waukegan (ABT-263)
Completed
- Healthy Female Subjects
- ABT-263
-
Waukegan, IllinoisSite Reference ID/Investigator# 23602
Nov 8, 2010
Chronic Lymphocytic Leukemia, Lymphomas, Leukemias Trial in United States (ABT-263)
Completed
- Chronic Lymphocytic Leukemia
- +2 more
- ABT-263
-
Encinitas, California
- +4 more
Oct 6, 2010
B-cell Chronic Lymphocytic Leukemia Trial (ABT-263)
Withdrawn
- B-cell Chronic Lymphocytic Leukemia
- ABT-263
- (no location specified)
Feb 25, 2010